Skip to main content
Top

Clinical and Translational Oncology

Issue 6/2013

Content (12 Articles)

Educational Series – Blue Series

Nanoemulsions and nanoparticles for non-melanoma skin cancer: effects of lipid materials

P. Severino, J. F. Fangueiro, S. V. Ferreira, R. Basso, M. V. Chaud, M. H. A. Santana, A. Rosmaninho, E. B. Souto

Educational Series – Red Series

Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

F. J. Afonso, U. Anido, O. Fernández-Calvo, S. Vázquez-Estévez, L. León, M. Lázaro, M. Ramos, L. Antón-Aparicio

Research Article

Comparisons of 5-aminolevulinic acid photodynamic therapy and after-loading radiotherapy in vivo in cervical cancer

T. Gui, Y. Wang, Y. Mao, J. Liu, S. Sun, D. Cao, J. Yang, K. Shen

Research Article

Intraoperative radiotherapy for the treatment of resectable locally advanced gastric adenocarcinoma: topography of locoregional recurrences and long-term outcomes

F. A. Calvo, C. V. Sole, R. Obregón, M. Gómez-Espí, C. González- San Segundo, L. González- Bayón, E. Alvarez, J. L. García-Sabrido

Research Article

Pilot study of feasibility and dosimetric comparison of prone versus supine breast radiotherapy

E. Fernández-Lizarbe, A. Montero, A. Polo, R. Hernanz, R. Morís, S. Formenti, A. Ramos

Research Article

Preoperative treatment with bevacizumab in combination with chemotherapy in patients with unresectable metastatic colorectal carcinoma

J. Figueras, S. Lopez-Ben, M. Alsina, J. Soriano, X. Hernandez-Yagüe, M. Albiol, R. Guardeño, A. Codina-Barreras, B. Queralt

Research Article

Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients

L. Manso, N. Valdiviezo, J. Sepúlveda, E. Ciruelos, C. Mendiola, I. Ghanem, E. Vega, R. Manneh, M. Dorta, H. Cortés-Funes

Open Access Research Article

Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish survey

J. L. Steegmann, J. M. Sánchez Torres, R. Colomer, Á. Vaz, J. López, I. Jalón, M. Provencio, A. González-Martín, M. Pérez

Research Article

Stereotactic ablative radiotherapy delivered by image-guided helical tomotherapy for extracranial oligometastases

C. V. Sole, J. L. Lopez Guerra, R. Matute, J. Jaen, F. Puebla, E. Rivin, A. Sanchez-Reyes, C. Beltran, C. Bourgier, F. A. Calvo, H. Marsiglia

Research Article

A novel peptide (Thx) homing to non-small cell lung cancer identified by ex vivo phage display

A. Koivistoinen, I. I. K. Ilonen, K. Punakivi, J. V. Räsänen, H. Helin, E. I. Sihvo, M. Bergman, J. A. Salo

Erratum

Erratum to: Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

F. J. Afonso, U. Anido, O. Fernández-Calvo, S. Vázquez-Estévez, L. León, M. Lázaro, M. Ramos, L. Antón-Aparicio

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine